IMNN
Price
$1.16
Change
+$0.76 (+190.00%)
Updated
May 23 closing price
Capitalization
16.96M
80 days until earnings call
VIGL
Price
$7.89
Change
+$5.58 (+241.56%)
Updated
May 23 closing price
Capitalization
368.24M
79 days until earnings call
Interact to see
Advertisement

IMNN vs VIGL

Header iconIMNN vs VIGL Comparison
Open Charts IMNN vs VIGLBanner chart's image
Imunon
Price$1.16
Change+$0.76 (+190.00%)
Volume$413.58M
Capitalization16.96M
Vigil Neuroscience
Price$7.89
Change+$5.58 (+241.56%)
Volume$3.71M
Capitalization368.24M
IMNN vs VIGL Comparison Chart
Loading...
IMNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNN vs. VIGL commentary
May 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNN is a StrongBuy and VIGL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 25, 2025
Stock price -- (IMNN: $1.16 vs. VIGL: $7.89)
Brand notoriety: IMNN and VIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNN: 4568% vs. VIGL: 602%
Market capitalization -- IMNN: $16.96M vs. VIGL: $368.24M
IMNN [@Biotechnology] is valued at $16.96M. VIGL’s [@Biotechnology] market capitalization is $368.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $298.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNN’s FA Score shows that 0 FA rating(s) are green whileVIGL’s FA Score has 0 green FA rating(s).

  • IMNN’s FA Score: 0 green, 5 red.
  • VIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, VIGL is a better buy in the long-term than IMNN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNN’s TA Score shows that 4 TA indicator(s) are bullish while VIGL’s TA Score has 7 bullish TA indicator(s).

  • IMNN’s TA Score: 4 bullish, 3 bearish.
  • VIGL’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, VIGL is a better buy in the short-term than IMNN.

Price Growth

IMNN (@Biotechnology) experienced а +139.72% price change this week, while VIGL (@Biotechnology) price change was +216.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.22%. For the same industry, the average monthly price growth was +3.23%, and the average quarterly price growth was -2.73%.

Reported Earning Dates

IMNN is expected to report earnings on Aug 13, 2025.

VIGL is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIGL($368M) has a higher market cap than IMNN($17M). VIGL YTD gains are higher at: 364.118 vs. IMNN (22.105). IMNN has higher annual earnings (EBITDA): -17.9M vs. VIGL (-91.27M). VIGL has more cash in the bank: 87.1M vs. IMNN (5.87M). IMNN has less debt than VIGL: IMNN (1.14M) vs VIGL (12.7M). IMNN (0) and VIGL (0) have equivalent revenues.
IMNNVIGLIMNN / VIGL
Capitalization17M368M5%
EBITDA-17.9M-91.27M20%
Gain YTD22.105364.1186%
P/E RatioN/AN/A-
Revenue00-
Total Cash5.87M87.1M7%
Total Debt1.14M12.7M9%
FUNDAMENTALS RATINGS
IMNN: Fundamental Ratings
IMNN
OUTLOOK RATING
1..100
99
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMNNVIGL
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 13 days ago
87%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
IMNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IRTC142.692.82
+2.02%
iRhythm Technologies
RDHL1.84-0.01
-0.54%
Redhill Biopharma Ltd
WVE5.95-0.09
-1.49%
Wave Life Sciences Ltd
ONIT36.04-0.85
-2.30%
Onity Group Inc.
BALL51.76-2.07
-3.85%
Ball Corp

IMNN and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNN has been loosely correlated with VIGL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNN jumps, then VIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNN
1D Price
Change %
IMNN100%
+190.58%
VIGL - IMNN
50%
Loosely correlated
+241.56%
PCSA - IMNN
31%
Poorly correlated
-0.58%
STOK - IMNN
30%
Poorly correlated
-1.27%
DNLI - IMNN
30%
Poorly correlated
-1.76%
DTIL - IMNN
29%
Poorly correlated
-1.29%
More

VIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIGL has been loosely correlated with IMNN. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if VIGL jumps, then IMNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIGL
1D Price
Change %
VIGL100%
+241.56%
IMNN - VIGL
50%
Loosely correlated
+190.58%
MRUS - VIGL
45%
Loosely correlated
+27.61%
OABI - VIGL
37%
Loosely correlated
-3.50%
ELVN - VIGL
36%
Loosely correlated
-3.13%
RCKT - VIGL
36%
Loosely correlated
-4.86%
More